Efficacy of interferon alpha in the treatment of refractory and sight threatening uveitis: a retrospective monocentric study of 45 patients - Wikidata - awgldk - TriplyDB

Efficacy of interferon alpha in the treatment of refractory and sight threatening uveitis: a retrospective monocentric study of 45 patients

Efficacy of interferon alpha in the treatment of refractory and sight threatening uveitis: a retrospective monocentric study of 45 patients

http://www.wikidata.org/entity/Q35763133

about

Effects of AIN457, a Fully Human Antibody to Interleukin-17A, on Psoriasis, Rheumatoid Arthritis, and Uveitis Emerging drugs for uveitis A Clinical Picture of the Visual Outcome in Adamantiades-Behçet's Disease Medical management of uveitis - current trends Current concepts and future directions in the pathogenesis and treatment of non-infectious intraocular inflammation.Therapeutic apheresis in autoimmune diseases.Current approach in the diagnosis and management of panuveitis.Immunopathogenesis of ocular Behçet's disease An update on the use of biologic therapies in the management of uveitis in Behçet's disease: a comprehensive review.Interobserver agreement in clinical grading of vitreous haze using alternative grading scales.The use of biologic agents in the treatment of ocular manifestations of Behcet's disease.Interventions for the treatment of uveitic macular edema: a systematic review and meta-analysis.Diagnostic techniques for inflammatory eye disease: past, present and future: a review.Ischemic retinal vasculitis and its management.Clinical Experience of Interferon Alfa-2a Treatment for Refractory Uveitis in Behçet's Disease.Assessment of vitreous haze using ultra-wide field retinal imaging.Ocular features of Behcet's disease: an international collaborative study Role of the retinal vascular endothelial cell in ocular disease Interferon-alpha in the management of patients with Behçet's disease.Interferons and their potential in the treatment of ocular inflammation.Birdshot uveitis: current and emerging treatment options A review and update on orphan drugs for the treatment of noninfectious uveitis Clinical review: Anti-TNFalpha therapies in uveitis: perspective on 5 years of clinical experience.Update on the therapy of Behçet disease.Clinical review: Update on treatment of inflammatory macular edema.Road to remission: a comprehensive review of therapy in uveitis.Biological agents for the treatment of uveitis.Biologic agents in inflammatory eye disease.Light on the horizont: biologicals in Behçet uveitis.The role of biologic agents in the management of non-infectious uveitis.New biologic-response modifiers in ocular inflammatory disease: beyond anti-TNF treatment.Gene therapy for noninfectious uveitis.Current and future treatments for Behçet's uveitis: road to remission.Therapy of ocular Behçet disease.Ocular Involvement of Behçet's Syndrome: a Comprehensive Review.A Major Review: Current Aspects of Ocular Behçet's Disease in Japan.Progress in the understanding and utilization of biologic response modifiers in the treatment of uveitis.Uveitic macular edema.The Role of IFN-alpha in Experimental and Clinical Uveitis.Therapeutic Apheresis in Hematologic, Autoimmune and Dermatologic Diseases With Immunologic Origin.

P2860

Q22299388-26125163-98FA-4055-AA39-E255D7B33804 Q24630848-34C34FF7-593B-432D-967C-7DBD03184146 Q26777598-80E15F3B-B0E9-4188-96C9-42D6EC8DDB27 Q27003399-F8C5C8AD-F3D4-44D0-8C43-8298E401A638 Q27693189-7ACEF109-3D23-449E-AB62-2B8432C3C56C Q33436347-CD32F08D-9183-4BB4-A29B-623910929D0D Q33737954-6C00C5BB-9247-42F6-BAA4-E94419DBDD57 Q33908937-5930F01D-7E11-4482-8F35-093BB4C149E3 Q33910781-996E6BEE-23FA-48E1-A920-3EB6E0FAE900 Q34005672-026C6239-435C-4EC3-8724-E81B92D665A2 Q34220221-A695E12D-C488-4C70-8F1E-B73DF7BEBEF1 Q34786343-201D595B-9A3D-4DF7-8B76-7F0A382E4D34 Q34910419-48D94525-4223-4D8D-A78F-F56BE2198C76 Q35170689-D8AB428E-C09A-4099-BCEA-0963882CE6A3 Q35778250-E373115F-1B76-4B93-8113-DC831FFDB290 Q36149355-47B11C07-FEE1-4A4A-A8D2-635B7E8AA00D Q36172359-2870D19C-F4DC-47F7-B731-3950FEF50566 Q36919959-CE0D4FB6-B1FA-4CAC-A672-239219B67452 Q37307804-175F6366-C4C1-4516-9650-0DBBAC6407B2 Q37406596-BA2B5DE7-3BF0-48F5-8273-A9AF8C4EC78E Q37412317-6E2BDA51-E7EC-43A1-A2F9-6BF7B33AE6B7 Q37632096-4B2CE740-1D70-4DF6-9FEC-9854FE28EC38 Q37650221-9B37A6CD-E074-4682-8755-DF4864085511 Q37712230-918F9381-CE1E-4B4E-B64D-F429F39F7F40 Q37804876-9DBC2F73-8DEB-4F6B-98E0-7199AFA9F171 Q37936459-8894252E-8ED0-402C-A890-C23C3F33CEA7 Q37984565-F20D7242-0802-4046-A155-58BB94DDD165 Q37997772-09EDFBBE-9D1C-4A41-8945-D312992B97A0 Q38004097-C0713507-86A0-4A8C-8988-C24F40078ACF Q38025152-8248BABC-F63E-48D9-8994-3ED155533C4C Q38057370-AA4AF1BF-4A30-45ED-A89E-68D6BDE82301 Q38060848-76B64322-959F-44C4-AEAE-B93EEF640891 Q38111308-F4A3E722-B64A-470A-81A8-2F16DEC1E323 Q38174652-46E4908E-4AEB-473E-948F-110D9CC66BB2 Q38211813-76BBBEDB-BF9C-4975-A813-80CB2E6CF4EE Q38545948-8EF7F026-8B1F-4F9A-88A6-26B1B0E5AE01 Q38773144-CD94415B-0321-401D-9B77-05276C92DEC2 Q38852119-22B4C0DF-B7F5-4F59-ABA8-AA90066A20C4 Q38856516-38E5B79D-4751-4112-B433-0CF3E8BBC914 Q38955520-CBEC5BE2-A38D-4A77-AD6E-8B76CFCE854F

P2860

Efficacy of interferon alpha in the treatment of refractory and sight threatening uveitis: a retrospective monocentric study of 45 patients

http://www.wikidata.org/entity/Q35763133

description

2006 nî lūn-bûn

@nan

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

2006年论文

@zh

2006年论文

@zh-cn

name

Efficacy of interferon alpha i ...... nocentric study of 45 patients

@ast

Efficacy of interferon alpha i ...... nocentric study of 45 patients

@en

type

label

Efficacy of interferon alpha i ...... nocentric study of 45 patients

@ast

Efficacy of interferon alpha i ...... nocentric study of 45 patients

@en

prefLabel

Efficacy of interferon alpha i ...... nocentric study of 45 patients

@ast

Efficacy of interferon alpha i ...... nocentric study of 45 patients

@en

P1433

Q35763133-3054A932-2DDC-46B0-B386-DEE82F26AE71

P1476

Q35763133-F824C73C-411A-4037-A783-61630C258CDA

P2093

Q35763133-03532688-9490-4C9D-B96C-2FBA47410C6B

Q35763133-438C0830-A39B-4B7C-B064-22820537F8FF

Q35763133-5AA037E6-5DE4-4A4A-A3CA-6CB4D5D6E2C3

Q35763133-67DBC048-D100-40C4-90BD-86354DDA6593

Q35763133-95E9799A-481A-4FBD-9316-8C69A9149E83

Q35763133-AE753EFA-EDE8-4D98-951A-D396A6DC73AF

Q35763133-CBC1B2A0-E564-4241-B58F-73E97009761E

Q35763133-CDF44377-EDEB-4569-9996-67F1FCF6A10F

Q35763133-D0A576B4-CFD5-409C-ADA5-36390E8932AD

P2860

Q35763133-005E39F8-9196-4A45-BB63-4AAF43BACEB2

Q35763133-084DFB19-2666-4D11-BE3B-89699A1F677D

Q35763133-0FC22BEE-F9C4-48B3-AA90-B4083A74917C

Q35763133-172D96F7-6EBB-488C-BA58-19DB7E75D7FC

Q35763133-18CDCEA3-03A7-4791-8B80-81C728D8D683

Q35763133-3406D1BD-833B-4D5E-8CC5-86ED5AC00AA0

Q35763133-44E61E93-EBA2-4BC4-82D9-596E26AA7772

Q35763133-48371869-7B03-473A-BCC8-0012C5B49E83

Q35763133-5829E069-B899-42FA-AFC8-1479BFDD072F

Q35763133-647764A1-B495-4834-8107-2BB2E97929D8

P304

Q35763133-0B093513-AF0E-4657-BE42-CFABBE36861C

P31

Q35763133-3F2F5289-308E-4830-9BDB-1A2B10698DA1

P356

Q35763133-7C973A3B-2AB6-4AE4-BD4B-CC830BE8C86E

P407

Q35763133-FB8B8DC5-B453-4F67-A708-10191E5C1B61

P433

Q35763133-FCE19664-CF66-4AB8-8A63-1C9AA890CA02

P478

Q35763133-F40E2FDD-271D-4815-9F3F-6840AE74F3B4

P50

Q35763133-03CC028E-8D8C-4CE7-925F-21D9E7E6F374

P577

Q35763133-C3ADF8B2-4AFE-4BDF-8A4D-BCBADB8397D4

P5875

Q35763133-A65C7D62-8410-4A0A-9722-218133161A0A

P698

Q35763133-BB6FB565-3ACD-4CC5-9067-DFB71FDD7AAD

P921

Q35763133-A00CEB22-C4D4-4306-BE0A-E10677415116

P932

Q35763133-0921C8C0-6100-4CF9-93A6-71ACAFBC6580

P356

BJO.2006.101550

P1433

British Journal of Ophthalmology

P1476

Efficacy of interferon alpha i ...... nocentric study of 45 patients

@en

P2093

Bahram Bodaghi

http://www.w3.org/2001/XMLSchema#string

Bertrand Wechsler

http://www.w3.org/2001/XMLSchema#string

Christine Fradeau

http://www.w3.org/2001/XMLSchema#string

Claire Lemaitre

http://www.w3.org/2001/XMLSchema#string

Céline Terrada

http://www.w3.org/2001/XMLSchema#string

Du Le Thi Huong

http://www.w3.org/2001/XMLSchema#string

Gael Gendron

http://www.w3.org/2001/XMLSchema#string

Nathalie Cassoux

http://www.w3.org/2001/XMLSchema#string

Phuc LeHoang

http://www.w3.org/2001/XMLSchema#string

P2860

Human recombinant interferon alfa-2a for the treatment of Behçet's disease with sight threatening posterior or panuveitis

Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop

Efficacy of interferon alfa-2a in severe and refractory uveitis associated with Behçet's disease.

Interferon alpha-2a treatment for serpiginous choroiditis.

Clinical toxicity of interferons in cancer patients: a review.

Bone marrow hypoplasia and fibrosis following interferon treatment.

Interferon alfa-2a in the treatment of Behçet disease: a randomized placebo-controlled and double-blind study.

Interferon alfa combined with azathioprine for the uveitis of Behçet's disease: an open study.

Treatment of ocular symptoms of Behçet's disease with interferon alpha 2a: a pilot study.

The use of interferon alpha in Behçet disease: review of the literature.

P304

335-339

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1136/BJO.2006.101550

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

91

http://www.w3.org/2001/XMLSchema#string

P50

Jean-Charles Piette

P577

2006-10-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6744383

http://www.w3.org/2001/XMLSchema#string

P698

17050581

http://www.w3.org/2001/XMLSchema#string

P921

P932

1857681

http://www.w3.org/2001/XMLSchema#string